All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q1 report for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) on April 17, 2025, reporting $80,000 in lobbying income.

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Pharmaceutical company.

All filings by TIBER CREEK GROUP · Everything TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 17, 2025

Income

$80,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Health Issues

Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023.

Issues related to intellectual property; S. 150 - Affordable Prescriptions for Patients Act of 2023; H.R. 6986/S. 3583 - A Bill to Address Patent Thickets.

Bills named in this filing 5

H.R. 4818
Treat and Reduce Obesity Act of 2023
S. 2407
Treat and Reduce Obesity Act of 2023
S. 150
Affordable Prescriptions for Patients Act of 2023
H.R. 6986
To address patent thickets.
S. 3583
A bill to address patent thickets.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.